BRD2 and progressive multifocal leukoencephalopathy: A short washout period may decrease the risk of post NAT disease re-activation, but may also increase the risk for carry-over PML: a PML that develops few months after cessation of NAT therapy and after initiating an alternative DMT (44–47).